Induction therapy in newly diagnosed multiple myeloma: Current research scenario and questions for the future
The outcomes of patients with newly diagnosed multiple myeloma (NDMM) have substantially improved over the last decade. Besides improved staging, diagnostic and prognostic tools leading to better risk-stratified approaches, a major contributing factor has been better induction regimens. The major em...
Main Authors: | Bhausaheb Bagal, Avinash Bonda |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Cancer Research, Statistics, and Treatment |
Subjects: | |
Online Access: | http://www.crstonline.com/article.asp?issn=2590-3233;year=2019;volume=2;issue=1;spage=76;epage=82;aulast=Bagal |
Similar Items
-
Kinetics of Renal Function during Induction in Newly Diagnosed Multiple Myeloma: Results of Two Prospective Studies by the German Myeloma Study Group DSMM
by: Friederike Bachmann, et al.
Published: (2021-03-01) -
Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments
by: Massimo Offidani, et al.
Published: (2021-02-01) -
Current diagnosis, risk stratification and treatment paradigms in newly diagnosed multiple myeloma
by: Gayathri Ravi, et al.
Published: (2021-01-01) -
The Role of Monoclonal Antibodies in Smoldering and Newly Diagnosed Transplant-Eligible Multiple Myeloma
by: Elena Zamagni, et al.
Published: (2020-12-01) -
Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients
by: Sinan Mersin, et al.
Published: (2021-08-01)